default author photo

Sara Schad

Memorial Sloan Kettering Cancer Center

New York, NY 10065

United States

SCHOLARLY PAPERS

1

DOWNLOADS

107

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Targeting Phosphatidylserine Enhances the Anti-Tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma

Number of pages: 57 Posted: 03 Sep 2019
Sadna Budhu, Rachel Giese, Aditi Gupta, Roberta Zappasodi, Sara Schad, Daniel Hirschhorn-Cymerman, Luis Felipe Campesato, Olivier De Henau, Mathieu Gigoux, Cailian Liu, Christopher A. Barker, Jedd D. Wolchok and Taha Merghoub
Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, Parker Institute for Cancer Immunotherapy, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Medicine and Memorial Sloan Kettering Cancer Center - Department of Medicine
Downloads 107 (654,668)

Abstract:

Loading...

phosphatidylserine, radiation therapy, PD-1, melanoma, immunotherapy, immune modulation